PubMed Health⌕ Search

Biomedical subjects

Jean-Paul Vallee

Publications and source records attributed to Jean-Paul Vallee.

4 recordsLinked to original sources
PubMed2005

Bone motion analysis from dynamic MRI: acquisition and tracking.

RATIONALE AND OBJECTIVES: For diagnosis, preoperative planning and postoperative guides, an accurate estimate of joint kinematics is required. It is important to acquire joint motion actively with real-time protocols. MATERIALS AND METHODS: We bring together MRI developments and new image processing methods in order to automatically extract active bone kinematics from multi-slice real-time dynamic MRI. We introduce a tracking algorithm based on 2D/3D registration and a procedure to validate the technique by using both dynamic and sequential MRI, providing a gold standard bone position measurement. RESULTS: We present our technique for optimizing jointly the tracking method and the acquisition protocol to overcome the trade-off in acquisition time and tracking accuracy. As a case study, we apply this methodology on a human hip joint. CONCLUSION: The final protocol (bFFE, TR/TE 3.5/1.1 ms, Flip angle 80 degrees , pixel size 4.7 x 2.6 mm, partial Fourier reduction factor of 0.65 in read direction, SENSE acceleration factor of 2, frame rate = 6.7 frames/s) provides sufficient morphological data for bone tracking to be carried out with an accuracy of 3 degrees in terms of joint angle.

Algorithms↗
PubMed2004

Comparative study of FAST gradient echo MRI sequences: phantom study.

PURPOSE: To investigate a balanced steady state free precession sequence (b-SSFP) under a large range of conditions and to compare its performance with other types of gradient echo sequences for dynamic imaging. MATERIALS AND METHODS: Balanced turbo field echo (b-TFE; Philips Medical Systems, Best, The Netherlands) was investigated in vitro at a range of T2/T1 along with T1-contrast enhanced turbo field echo (T1-TFE) and turbo field echo (TFE) so that a comparison could be made. Performance was quantified in terms of the initial slope of the signal-to-noise ratio (SNR) vs. 1/T1 curve (sensitivity) and the range of 1/T1 before signal saturation (contrast dynamic range [CDR]). RESULTS: The b-TFE sequence was found to best perform, in terms of an optimal CDR, with a 90 degrees flip angle (FA), saturation preparation, and short inversion time. Using these parameters, the sensitivity was also higher than that of the TFE sequence and T1-TFE sequence under their respective optimal conditions. For detection of small changes in contrast agent concentration (0.0-0.1 mM), b-TFE was also found to be the sequence of choice, with optimized parameters as follows, 90 degrees FA, shortest TR/TE, and no magnetization preparation. The smallest matrices gave the highest signal sensitivity for all three sequences. CONCLUSION: The CDR of b-TFE was much narrower than that of T1-TFE but could be widened under optimized conditions. The sensitivity of the b-TFE technique was the highest of the three sequences under all conditions tested.

Contrast Media↗
PubMed2003

Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation.

PURPOSE: To compare in the entire liver, the hepatic kinetics of gadobenate dimeglumine (Gd-BOPTA) and gadopentetate dimeglumine (Gd-DTPA) and to evaluate the hepatic transport of Gd-BOPTA. MATERIALS AND METHODS: The authors studied both contrast agents in isolated perfused rat livers by measuring the magnetic resonance (MR) signal intensity (SI) in 12 rats, as well as the gadolinium concentrations in hepatic tissues in 42 rats. The intrahepatic transport of Gd-BOPTA was investigated with pharmacologic antagonism by using bromosulfophthalein. MR imaging was performed at 1.5 T with a fast gradient-echo T1-weighted MR sequence. RESULTS: The hepatic kinetics based on the MR SI measured over time showed a rapid steady state during Gd-DTPA perfusion, while the SI continuously increased during the 30-minute Gd-BOPTA perfusion period. The pharmacokinetic modeling indicated that the half-lives of Gd-DTPA entry and exit were identical (mean, 1.3 minutes +/- 0.9 [standard error of mean]) and shorter than those observed with Gd-BOPTA (P <.001). The uptake of Gd-BOPTA was faster (mean half-life, 4.8 minutes +/- 0.3) than the washout (mean half-life, 17.5 minutes +/- 2.8) (P =.001). The combined perfusion of bromosulfophthalein and Gd-BOPTA decreased the SI enhancement in comparison with the perfusion of Gd-BOPTA alone (mean, 0.56 +/- 0.03 vs 2.54 +/- 0.39, P <.001). The entry and exit kinetic parameters obtained during the perfusion of Gd-BOPTA plus bromosulfophthalein were identical and comparable to those obtained during Gd-DTPA perfusion (P =.95). Acute bile duct ligation did not interfere with the uptake of Gd-BOPTA in hepatocytes, but it slowed down the excretion by approximately 50%. Measurements of gadolinium concentrations in hepatic tissues confirmed these findings. CONCLUSION: In the liver, the hepatospecific contrast agent Gd-BOPTA enters into hepatocytes likely through the organic anion transporting peptide 1.

Animals↗